Prenatal Vitamin D Benefit In Preventing Childhood Asthma Fades By Age 6
Executive Summary
University of Rochester researchers say a benefit of daily prenatal vitamin D in preventing asthma in children up to 3 found in their 2016 study doesn't extend until age 6. They encourage more research, including analyzing whether supplementation should continue in young children.
You may also be interested in...
Prenatal vitamin E and asthma
Children are more likely to develop wheezing and asthma by age 5, if mothers do not have a sufficient intake of vitamin E during pregnancy, according to a study published in the September American Journal of Respiratory & Critical Care Medicine. The vitamin E levels and respiratory status of 1,253 mothers and children were assessed over a five-year period, Graham Devereux, MD, PhD, et al., Department of Environmental & Occupational Medicine, University of Aberdeen, UK, state. In a previous study, the researchers assessed vitamin E levels in 1,856 mothers at 12 weeks gestation and obtained symptom questionnaire data from 1,253 children. In light of the new findings, children born to mothers whose intakes of vitamin E ranked in the lowest quintile were five times more likely to manifest early persistent asthma than mothers with vitamin E intakes in the highest quintile, Devereux et al. state. The researchers suggest the relationship between prenatal vitamin E intake and children's rates of asthma "warrants further investigation," adding that vitamin E supplementation in adults who have asthma has not shown to provide clinical benefits...
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.